Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gall Bladder Cancers”

270 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 270 results

Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Large-scale testing (Phase 3)WithdrawnNCT03579758
What this trial is testing

Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer

Who this might be right for
Stage I Gallbladder Cancer AJCC v8Stage II Gallbladder Cancer AJCC v8Stage IIA Gallbladder Cancer AJCC v8+4 more
Emory University
Not applicableStudy completedNCT00489515
What this trial is testing

Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder

Who this might be right for
Colorectal CancerGallbladder CancerGastric Cancer+2 more
Wake Forest University Health Sciences 115
Not applicableUnknownNCT05237193
What this trial is testing

A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up

Who this might be right for
Biliary Tract NeoplasmsPancreatic CarcinomaGallbladder Cancer+1 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 400
Not applicableStudy completedNCT06223061
What this trial is testing

Global Evaluation of Cholecystectomy Knowledge and Outcomes

Who this might be right for
GallstoneGallbladder CancerBile Duct Injury
University of Edinburgh 53,708
Large-scale testing (Phase 3)Study completedNCT04924062
What this trial is testing

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension Study

Who this might be right for
Biliary Tract Carcinoma
Merck Sharp & Dohme LLC 158
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04430738
What this trial is testing

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

Who this might be right for
Colorectal CarcinomaGastric AdenocarcinomaGEJ Adenocarcinoma+3 more
Seagen, a wholly owned subsidiary of Pfizer 40
Testing effectiveness (Phase 2)Study completedNCT01007552
What this trial is testing

Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts

Who this might be right for
Cholangiocarcinoma
Roswell Park Cancer Institute 50
Testing effectiveness (Phase 2)Study completedNCT00005938
What this trial is testing

DX-8951f in Treating Patients With Biliary Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Daiichi Sankyo
Testing effectiveness (Phase 2)Active Not RecruitingNCT04308174
What this trial is testing

Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer

Who this might be right for
Biliary Tract NeoplasmsGallbladder CancerCholangiocarcinoma
Asan Medical Center 45
Not applicableEnded earlyNCT00414843
What this trial is testing

Storage of Bile From Routine Procedures to Study Risk Factors

Who this might be right for
Gallbladder CancerCholangiocarcinomaBiliary Tract Cancer
Indiana University School of Medicine 390
Early research (Phase 1)UnknownNCT02662348
What this trial is testing

T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System

Who this might be right for
Esophageal CancerGastric CancerPancreatic Cancer+3 more
Yi Miao 6
Large-scale testing (Phase 3)Looking for participantsNCT05482516
What this trial is testing

Evaluating Novel Therapies in ctDNA Positive GI Cancers

Who this might be right for
Colon AdenocarcinomaRectal AdenocarcinomaGastric Adenocarcinoma+4 more
Georgetown University 20
Not applicableUnknownNCT05718115
What this trial is testing

Deep Learning Radiogenomics For Individualized Therapy in Unresectable Gallbladder Cancer

Who this might be right for
Gallbladder Cancer
Post Graduate Institute of Medical Education and Research, Chandigarh 75
Large-scale testing (Phase 3)Looking for participantsNCT06712420
What this trial is testing

Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)

Who this might be right for
Gall Bladder Carcinoma
Rajiv Gandhi Cancer Institute & Research Center, India 114
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT01825603
What this trial is testing

ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer

Who this might be right for
Ampulla of Vater AdenocarcinomaGallbladder AdenocarcinomaMetastatic Pancreatic Adenocarcinoma+17 more
University of Nebraska 17
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Load More Results